EXECUTIVE CALL SUMMARY: FormFactor, Inc. (10/28/26)

FormFactor’s Q3 2026 results support higher normalized earnings expectations and a constructive fundamental assessment, but not extrapolation of the reported 56.5% gross margin or $1.04 adjusted EPS. The central investment development was an improvement in underlying manufacturing economics, accompanied by initial commercial penetration of important GPU designs and the first production shipment from Farmers Branch. Approximately $10.5 million of nonrecurring gross-profit benefits materially enhanced reported profitability. Excluding those benefits, adjusted gross margin was approximately 52.7% and adjusted EPS approximately $0.93. Those normalized results remain strong, but they establish a materially different earnings baseline from the headline figures.

Revenue of $280.5 million increased 8.6% sequentially and 38.4% year over year. Adjusted EPS exceeded the supplied Bloomberg consensus by 22.4%, while revenue exceeded consensus by 3.4%. The disproportionate earnings outperformance reflected better manufacturing efficiency, favorable discrete items and operating expenses below the prior plan. Importantly, substantial tariff refunds were already anticipated in management’s Q3 guidance. The quarter therefore cannot be characterized either as an entirely operational earnings beat or as an entirely refund-driven beat. Both the expected benefit embedded in guidance and the incremental operational improvement must be recognized.

The forward outlook is stronger than consensus but restrained by capacity. Q4 revenue guidance of $275 million to $295 million has a midpoint only 1.6% above Q3, despite management’s description of broad demand strength. Adjusted EPS guidance of $0.86 to $1.04 compares favorably with Bloomberg consensus of $0.80. After removing the expected Q4 tariff refund, midpoint EPS is approximately $0.93, essentially unchanged from normalized Q3 earnings. The near-term financial trajectory is therefore better described as strong recurring profitability approaching a production ceiling than as continued sequential earnings acceleration.

Farmers Branch is now the principal determinant of incremental earnings revisions. Management expects approximately $400 million of annual probe-card revenue capacity at the end of 2027, with capacity increasing approximately linearly during the year. That is neither $400 million of recognized 2027 revenue nor a guaranteed revenue commitment. The first production shipment reduces initial commissioning risk, but manufacturing transfer, MEMS front-end qualification, customer acceptance, yield development and utilization remain material execution variables.

The appropriate investment stance is constructive on the operating franchise and disciplined on valuation. The call strengthens confidence that FormFactor can sustain substantially better profitability than its historical model, while broadening its participation across CPUs, GPUs, custom ASICs, memory and photonics. It does not eliminate semiconductor cyclicality, establish that every qualified design will reach meaningful production, or justify valuing temporary refunds as recurring earnings. The most consequential upcoming evidence will be incremental saleable output from Farmers Branch, approximately 53% underlying gross margins during the ramp, and conversion of GPU and ASIC qualifications into diversified production revenue.

QUARTERLY PERFORMANCE AND THE SOURCES OF OUTPERFORMANCE

Q3 revenue increased from $258.2 million in Q2 and $202.7 million in Q3 2025 to $280.5 million, producing the company’s 4th consecutive quarterly revenue record. Against the prior revenue guidance midpoint of $270 million, the beat was $10.5 million, or 3.9%. Against the $280 million upper bound, however, the beat was only approximately $0.5 million. This distinction matters: the reported results were exceptional primarily because of profitability and earnings conversion, rather than a dramatic overshoot of the anticipated revenue range.

The supplied Bloomberg notice shows revenue consensus of $271.3 million, adjusted EPS consensus of $0.85 and adjusted gross-margin consensus of 53.8%. Actual revenue exceeded consensus by approximately $9.2 million, adjusted EPS exceeded consensus by $0.19, and adjusted gross margin exceeded consensus by 270 basis points. Against management’s previous adjusted EPS guidance of $0.86, plus or minus $0.09, actual EPS exceeded the midpoint by $0.18 and the upper bound by $0.09. The prior adjusted gross-margin midpoint was 54%, with an upper bound of 55.5%.

Historical earnings growth was substantial. Adjusted EPS increased from $0.33 in Q3 2025 to $1.04, while GAAP EPS increased from $0.20 to $0.93. Adjusted net income increased from $25.7 million to $82.3 million. Adjusted operating income increased from $28.6 million to $94.1 million, with operating margin expanding from approximately 14.1% to 33.5%. These comparisons demonstrate a genuine change in earnings capacity, although the current-quarter discrete benefits inflate the apparent magnitude.

Sequentially, adjusted operating income increased approximately 30.7% on 8.6% revenue growth. Adjusted operating expenses declined from $65.7 million to $64.4 million, despite higher factory preproduction spending. Operating expenses fell from approximately 25.4% of revenue to 23.0%. That combination produced unusually high incremental operating profit, but the resulting incremental margin should not be extrapolated because it includes discrete gross-profit benefits and a sequential decline in operating expenses.

The release also indicates that taxes were not responsible for the sequential EPS acceleration. The adjusted effective tax rate increased to 17.6% from approximately 16.2% in Q2, calculated from the release’s reconciliation. Diluted shares declined only approximately 0.2% sequentially. Earnings growth was therefore predominantly attributable to operating improvement and discrete gross-profit benefits, rather than a lower tax rate or material share-count reduction.

EARNINGS QUALITY AND THE NEW GROSS-MARGIN BASELINE

The most important financial distinction is between the reported 56.5% adjusted gross margin and the approximately 53% operating baseline. Management identified approximately $10.5 million of benefits that were not expected to recur, including $8.6 million of tariff refunds and approximately $1.9 million of other benefits, principally associated with favorable Quantum-business subcomponent costs. These items were retained in company-reported non-GAAP earnings. Non-GAAP classification therefore did not make the reported quarter fully representative of recurring profitability.

Subtracting $10.5 million from reported adjusted gross profit of approximately $158.5 million produces normalized gross profit of approximately $148.0 million and a gross margin of approximately 52.7%. Applying the reported 17.6% adjusted tax rate to the excluded benefits produces approximately $8.7 million of after-tax benefit, or approximately $0.11 per diluted share. Normalized adjusted EPS was consequently approximately $0.93. This is an analytical normalization, not a separately reported company metric, and assumes the quarter’s adjusted tax rate is appropriate for the excluded items.

Management explicitly quantified the tariff contribution at approximately $0.09 per share. The remaining discrete benefits account for approximately $0.02 per share under the same tax assumption. Annualizing reported Q3 EPS would therefore imply approximately $4.16, whereas annualizing the normalized result produces approximately $3.71. Neither is a full-year forecast, but the difference illustrates the valuation error that would result from treating the headline quarter as a clean earnings base.

The underlying improvement remains significant. McKinnis stated, “We now view around 53% as the gross margin baseline at Q3 volumes.” In Q&A, that baseline was compared with 51% to 51.5% discussed previously. The improvement is approximately 150 to 200 basis points, despite a DRAM mix shift away from HBM toward DDR5. Management attributed the change to better cycle times, yields, labor performance, manufacturing spending and other production costs. The evidence supports a stronger operating model, although the baseline remains explicitly conditional on Q3-level production volumes.

The distinction between normalization and surprise attribution is particularly important. The July earnings call already anticipated approximately 300 basis points of Q3 tariff-refund benefit. Consequently, removing the entire $8.6 million refund from the earnings surprise would overstate the extent to which unexpected items drove outperformance. Management’s prior plan already included a substantial refund. The relevant comparison is the change from the refund benefit assumed in that plan, plus the additional Quantum-related benefits and the operational variance. The precise refund assumptions embedded in Bloomberg consensus were not provided, preventing an exact recurring-versus-discrete decomposition of the consensus beat.

The prior management plan provides a useful operating bridge. Revenue of $270 million, gross margin of 54% and operating expenses of $70 million implied adjusted operating income of approximately $75.8 million. Actual adjusted operating income was $94.1 million, approximately $18.3 million higher. Mechanically, approximately $5.7 million came from additional revenue valued at the planned margin, approximately $7.0 million from gross-margin outperformance on actual revenue, and approximately $5.6 million from lower operating expenses. This bridge confirms that expense discipline and production economics were important contributors independently of the anticipated refunds.

The supplied transcript contains an inconsistent passage describing gross margin excluding discrete benefits as between 52.5% and 58%. That range is not supported by the disclosed arithmetic or the subsequent explicit 53% baseline. The approximately 52.7% calculation and management’s repeated 53% characterization provide the internally consistent basis for analysis.

Q4 GUIDANCE AND FULL-YEAR IMPLICATIONS

Q4 revenue guidance is $285 million, plus or minus $10 million. The midpoint exceeds Bloomberg consensus of $281.5 million by approximately $3.5 million, or 1.2%. Adjusted EPS guidance is $0.95, plus or minus $0.09, with the midpoint 18.8% above consensus of $0.80. Even the EPS lower bound exceeds consensus. Adjusted gross-margin guidance of 54%, plus or minus 150 basis points, also exceeds the 51.7% consensus estimate across the entire guided range.

The revenue outlook is less emphatic than the earnings outlook. Sequential revenue growth at the midpoint slows to 1.6%, compared with 8.6% in Q3 and 14.2% in Q2. Management directly connected that moderation to manufacturing limitations. McKinnis stated, “We’re operating kind of at the limits of what our current footprint can do.” This explanation is consistent with the company’s strong demand commentary and extensive discussion of capacity, but it remains management’s assessment rather than independently quantified demand visibility. No backlog, book-to-bill ratio or committed utilization schedule was provided.

The expected approximately $2 million Q4 tariff refund contributes approximately 70 basis points to midpoint gross margin. Removing it reduces the 54% margin outlook to approximately 53.3%. Depending on the eventual diluted share count and tax rate, the refund contributes approximately $0.02 to EPS, leaving normalized midpoint EPS near $0.93. The apparent decline from reported Q3 EPS of $1.04 to Q4 guidance of $0.95 is therefore substantially explained by the reduction in discrete benefits, rather than a comparable deterioration in underlying earnings.

The operating-income bridge is consistent with that interpretation. Q4 midpoint revenue, gross margin and operating expenses imply approximately $84.9 million of adjusted operating income. Excluding the refund produces approximately $82.9 million, compared with approximately $83.6 million in normalized Q3 operating income. Recurring operating profit is effectively flat, while recurring operating margin declines modestly because operating expenses rise faster than revenue.

Q4 adjusted operating expenses are expected to increase to approximately $69 million, plus or minus $2 million, from $64.4 million in Q3. Importantly, this occurs despite some factory costs moving out of operating expenses. Excluding the approximately $5 million of Farmers Branch costs expected to remain in operating expenses, the Q4 midpoint implies approximately $64 million of other operating expenses, compared with approximately $58 million in Q3 after excluding its $6.4 million of factory preproduction costs. The unusually low Q3 expense base should therefore not be treated as permanently fixed.

The published 9-month revenue total of $764.9 million, combined with Q4 guidance, implies full-year revenue of approximately $1.040 billion to $1.060 billion, with a midpoint near $1.050 billion. The $1 billion milestone is therefore supported even at the low end of the revenue range. Adding the reported 9-month adjusted EPS of $2.42 to Q4 midpoint guidance produces approximately $3.37, although actual full-year EPS will depend on annual weighted-average shares, including the timing of the Teradyne issuance.

The Q4 outlook is new guidance for a new period, not a revision to an earlier Q4 range presented in the supplied materials. The explicit comparable-period changes elsewhere in the call are the higher 2026 Triton expectation and lower 2026 cash capital-spending estimate. The long-term $1.6 billion revenue, 55% gross-margin and $5 adjusted EPS framework was reiterated, not formally increased or accelerated.

FARMERS BRANCH: CAPACITY, TIMING AND EXECUTION RISK

Farmers Branch crossed an important operational milestone with qualification of its assembly and test operations and shipment of its first production probe card. Management had previously expected initial revenue near the end of 2026 or beginning of 2027. The October shipment represents a modest acceleration of first revenue, not evidence that the entire factory buildout or all customer qualifications have been pulled forward by a similar interval.

The initial production scope is narrower than a fully integrated factory. Slessor explained that the facility is initially ramping assembly and test for foundry and logic products, with the MEMS front end to be added during 2027. The distinction is material because assembly and test qualification does not prove readiness across the complete manufacturing process. The remaining front-end ramp introduces additional equipment, process-transfer, yield and customer-qualification dependencies.

Management expects approximately $400 million of annual probe-card revenue capability exiting 2027. McKinnis explicitly cautioned, “That’s a capability exit, not necessarily the revenue.” This statement should govern financial modeling. An annualized exit capability measures potential production at the end of the ramp. It does not establish sales recognized during the ramp, utilization, customer acceptance, shipment timing or incremental consolidated revenue.

A perfectly linear increase from approximately $0 to $400 million of annual capacity over 2027 would provide approximately $200 million of production opportunity during the year. Under a continuous linear approximation, the quarterly capacity-equivalent amounts would be approximately $12.5 million, $37.5 million, $62.5 million and $87.5 million. These are illustrative mathematical implications, not management revenue forecasts. They demonstrate why the expansion provides considerably more relief in the 2nd half than in Q1.

Even that approximately $200 million opportunity should not automatically be added to the existing business. Some production will be transferred from existing locations, qualification can lag installed capacity, and capacity utilization depends on the timing of customer demand. Foundry and logic transfers are expected to free DRAM capacity at Livermore, creating a broader network benefit. However, transferred production, newly available DRAM capacity and Texas capacity cannot all be counted as independent incremental revenue without a consolidated manufacturing bridge.

The customer-selection strategy is pragmatic. Management intends to prioritize customers with practical, aggressive qualification schedules rather than leave capacity idle during prolonged acceptance processes. This should improve early utilization, but it also makes the ramp sensitive to individual customer readiness. Maintaining product quality while accelerating qualifications is essential because probe reliability, contact performance and test repeatability affect customer yield interpretation and production economics.

The investment implication is that the main constraint has shifted. The company has demonstrated an ability to extract more output from its existing footprint, but management now describes those gains as increasingly difficult to repeat. Future growth depends more heavily on delivering new manufacturing capacity than on continued optimization of the old footprint. The risk profile consequently shifts from demand conversion within proven facilities toward commissioning, qualification and utilization of a new manufacturing platform.

GROSS-MARGIN EXPECTATIONS DURING THE FACTORY RAMP

Management expects 2027 gross margins to remain near the current approximately 53% baseline as higher volumes and operational efficiency offset temporary ramp inefficiencies. This is a constructive commitment because new factories typically generate underabsorption, training costs, duplicate processes and immature yields. It is not a commitment to sustain the reported 56.5% Q3 margin, nor is it guidance for immediate achievement of the long-term 55% target.

The 53% expectation also contains an important economic tradeoff. Growth-related operating leverage is expected to be consumed partly by ramp costs rather than flow entirely into higher gross margins. Revenue growth can therefore remain attractive while gross margins appear flat. Conversely, a slower ramp can affect both the numerator and denominator: fewer shipments reduce absorption while staffing and other fixed costs continue.

Accounting classification will complicate sequential comparisons. Q3 included approximately $6.4 million of preproduction costs in operating expenses. In Q4, management expects approximately $5 million of startup costs in cost of revenues and approximately $5 million remaining in operating expenses. At $285 million of revenue, $5 million is equivalent to approximately 175 basis points of gross margin. Moving an expense between these categories changes gross margin and operating-expense ratios but does not, by itself, change operating profit or cash generation.

The combined Q4 factory-cost expectation is approximately $10 million across the income statement, above Q3’s approximately $6.4 million. It would therefore be incorrect to interpret the transition as a simple disappearance of startup expense or to add back the operating-expense reduction while ignoring the corresponding cost-of-revenue burden. The economically relevant measures are total factory spending, incremental gross profit from saleable output and consolidated operating income.

Management expects the factory to be gross-margin accretive after the initial ramp is complete. However, it declined repeated requests to quantify the eventual accretion or provide a detailed bridge of 2027 headwinds and offsets. That limits precision. The call supports a stable underlying 2027 margin framework and eventual accretion, but not a specific standalone factory margin, quantified project return or predetermined post-ramp margin step-up.

FOUNDRY AND LOGIC: BROADER DEMAND AND EARLY SHARE-GAIN EVIDENCE

Foundry and logic revenue increased approximately 10% sequentially, and management expects further growth in Q4. The demand base includes PCs, mobile, data-center CPUs and networking, with incremental opportunities in GPUs and hyperscaler custom ASICs. The call therefore describes a broader driver set than a narrow GPU-only recovery.

Data-center CPU demand was identified as a particularly important contributor. Management described a longstanding customer approaching 10% of company revenue in Q3 and potentially exceeding that threshold in Q4, alongside exposure to fabless x86 and ARM-based processors. The customer was not explicitly identified in that discussion. At current company scale, a 10% customer represents approximately $28 million of quarterly revenue, making renewed CPU strength financially meaningful.

The GPU disclosure was commercially significant: FormFactor shipped probe cards for a single GPU design to the leading foundry in multimillion-dollar volumes. This demonstrates progression beyond an exclusively developmental relationship into an initial production program. Nevertheless, the disclosure establishes neither broad penetration across GPU architectures nor a quantified share position. Management expects meaningful gains in 2027, but those gains remain dependent on capacity and subsequent customer production ramps.

Custom ASIC progress is similarly encouraging but not fully quantified. Slessor stated that the company had qualified and shipped multiple units, while remaining constrained by “our ability to produce in volume.” The response did not provide customer-specific production revenue, a design count, contracted capacity or a confirmed qualification timetable for the Google TPU opportunity referenced by the analyst. Initial shipments and qualification progress should therefore be separated from large-volume commercial adoption.

The technical argument for stronger probe-card content is credible. Higher interface speeds, power density and advanced chiplet packaging increase demands on electrical performance, contact density, current delivery and test integrity. Early identification of defective die becomes more valuable as downstream assembly combines expensive components. However, the claim that advanced MEMS technology is a requirement for cost-effective testing is management’s competitive positioning, not proof that FormFactor uniquely captures the entire opportunity.

TSMC-related business diversification is favorable but incomplete as a risk mitigant. Management described a progression from mobile application processors toward a broader mix of high-performance-compute projects and Triton systems. That reduces dependence on an individual program within the customer relationship. It does not remove concentration in the foundry ecosystem, common process-node transitions, geopolitical exposure or the ultimate capital-spending budgets funding those designs.

DRAM, HBM AND THE IMPORTANCE OF MIX RESILIENCE

DRAM revenue was essentially unchanged from Q2’s record level, but the composition shifted materially from HBM toward DDR5. Management attributed the change to customers reallocating wafer starts toward DDR products to capture attractive pricing and profitability. Because probe cards are specific to customer chip designs, the company’s product mix changes with those production decisions.

The main positive signal is that strong profitability was maintained during a less favorable DRAM mix. Historically, the company’s gross margin was more dependent on the proportion of higher-margin products. Management now argues that manufacturing cost reductions have improved DRAM economics sufficiently to reduce company-level mix sensitivity. Slessor stated that there was “very little contribution for price increases” in the DRAM margin improvement.

That characterization matters because manufacturing-cost improvement is generally more defensible than a temporary scarcity-driven price increase. Better yields, shorter cycle times and more efficient resource use can persist beyond the current DRAM pricing environment. However, the company did not quantify standalone DDR5 margins, HBM margins or the remaining gap between DRAM and foundry and logic. Record consolidated margins, particularly when enhanced by refunds, do not establish the exact magnitude of DRAM-specific improvement.

The HBM decline should not automatically be interpreted as evidence of weakening structural HBM demand. Management described a product-allocation decision within a constrained DRAM market and pointed to HBM4E and HBM5 design activity. Conversely, design-funnel commentary is not equivalent to committed production revenue. The appropriate conclusion is that the quarter’s HBM mix decline appears consistent with customer production optimization, while the longer-term demand claim still requires confirmation through future shipments.

Management’s response to HBM destacking was also more nuanced than a simple content-loss narrative. FormFactor has differentiation in final stack testing. Holding the total number of memory die constant, moving from 12-high stacks to 8-high stacks would increase completed stack count by 50%. That can increase final-stack test opportunities even though each stack contains fewer die. This is a conditional physical relationship, not a forecast for probe-card revenue: total die demand, installed capacity, parallelism, test time and card reuse can all change.

The question about lower per-pin speed requirements did not produce evidence of an imminent adverse specification change. Management instead emphasized increasing performance requirements across the HBM4E and HBM5 roadmap. Higher speed can support differentiation, but test intensity cannot be inferred from pin speed alone. Interface width, parallel test architecture, contact count, signal integrity and qualification requirements also influence probe-card value and productivity.

PHOTONICS AND SYSTEMS: A GROWING CONTRIBUTOR, NOT YET THE DOMINANT BUSINESS

Systems revenue reached $59.5 million, increasing $11 million, or approximately 22.7%, sequentially. This represented approximately 21.2% of consolidated revenue and almost 49% of the company’s sequential revenue increase. Systems was therefore a major contributor to quarterly growth despite remaining smaller than Probe Cards. Probe Cards revenue, calculated as consolidated revenue less Systems, was approximately $221.0 million, increasing approximately 5.4% sequentially.

Systems gross margin increased to 61%, with management attributing approximately half of the sequential improvement to volume leverage and the remainder to benefits not expected to recur. The company did not disclose a sufficiently detailed segment allocation of the discrete items to establish a precise recurring Systems margin. The appropriate conclusion is that Systems profitability improved materially, but 61% should not be treated as a durable segment baseline.

Triton expectations have increased substantially during 2026. Management began the year expecting $10 million to $20 million and now expects more than $30 million. Relative to the original $15 million midpoint, the current expectation is more than 100% higher; relative to the original upper bound, it is more than 50% higher. However, the July call had already raised expectations above $20 million and anticipated reaching approximately $20 million by the end of Q3. The current update is an additional increase, not the entirety of the improvement from the original annual plan.

The CEO explicitly corrected the premise that Triton had generated a meaningful prior-year revenue base. Triton revenue was $0 in 2025. Growth into 2026 should therefore be described as initial commercialization to more than $30 million, not approximately 4x growth from a prior-year sales base. At a $30 million reference level, Triton represents approximately 2.9% of implied 2026 company revenue. It is strategically important and potentially fast-growing, but it is not yet the dominant consolidated earnings driver.

The company’s positioning in test insertion 1 is strategically attractive. Testing photonic integrated circuits before combining them with electronic integrated circuits helps establish known-good die and avoid integrating defective components into more expensive assemblies. This creates a common economic rationale across CPO and NPO architectures. Exposure to pluggables further broadens the application set, although management clarified that some pluggable opportunities use derivative technology rather than the Triton system itself.

The architecture breadth reduces dependence on a single packaging outcome, but not all concentration has been removed. Management acknowledged that current CPO demand is dominated by a single ecosystem. Its assertion that photonics adoption is “a question of when and not if” expresses confidence in the technology’s long-term role, not certainty regarding deployment schedules. Customer rollout timing, test duration, optical coupling efficiency, yields and system productivity can all produce uneven equipment orders.

Triton’s manufacturing model is less vertically integrated than the probe-card business. Management described integration and assembly of externally sourced subcomponents and stated, “We do not expect capacity to be a constraint on the growth of that business.” This creates a potential growth outlet while probe-card capacity remains constrained. It does not eliminate supplier availability, qualification, integration or customer-acceptance risk.

The approximately $400 million served-market opportunity referenced for 2030 is a market estimate, not company revenue guidance. The call did not specify future market share, installed-base monetization, recurring revenue content or the economics of replacement demand. Tighter integration of Keystone Photonics may improve control of differentiated optical coupling technology and system performance, but its incremental financial contribution was not quantified.

TERADYNE: STRATEGIC VALIDATION, FUNDING AND DILUTION

The expanded Teradyne collaboration strengthens FormFactor’s position within the semiconductor-test ecosystem. Together with the existing Advantest partnership, it supports interoperability with both leading ATE suppliers. The strategic benefit is broader access to customer qualification workflows and coordinated development across high-performance compute, advanced packaging, HBM and silicon photonics.

The open-ecosystem emphasis is commercially important. Customers retain the ability to choose probe cards and testers suited to their architectures rather than being compelled into a single integrated combination. This can support FormFactor’s independent role and reduce integration friction. However, the collaboration does not disclose purchase commitments, guaranteed attach rates or minimum revenue. Strategic endorsement should not be treated as contracted demand.

The October 13 Form 8-K provides financing detail absent from the call. Teradyne agreed to purchase 2,234,887 newly issued common shares for approximately $300 million, implying approximately $134.24 per share. Relative to Q3 diluted weighted-average shares, the issuance represents approximately 2.8% additional shares before subsequent equity-compensation effects. The financing strengthens liquidity but must be reflected in per-share earnings estimates.

The announcement and filing described the investment as subject to closing conditions, with closing expected in Q4. The Q3 cash balance therefore does not include the $300 million. Adding the proceeds to September cash produces a conditional pro forma liquidity illustration, not a reported quarter-end balance or independent confirmation of closing.

The investment’s greatest immediate value is financial flexibility rather than removal of a funding emergency. FormFactor already had a substantial net-cash position and strong cash generation. The proceeds can support manufacturing investment and targeted acquisitions, but cannot independently accelerate equipment qualification, workforce learning or customer acceptance. Management’s unchanged capital-allocation priorities also leave open the possibility that some capital will fund acquisitions rather than the existing factory program.

CASH FLOW, CAPITAL SPENDING AND BALANCE-SHEET QUALITY

Q3 operating cash flow was $104.3 million, increasing from $61.8 million in Q2 and $27.0 million a year earlier. Company-defined free cash flow was $64.8 million, compared with $52.6 million sequentially and $19.7 million a year earlier. Free cash flow represented approximately 23.1% of revenue and 78.7% of adjusted net income, despite a significant increase in capital spending.

The company’s free-cash-flow definition is slightly broader than operating cash flow less capital expenditures. Q3 operating cash flow of $104.270 million, less $39.648 million of capital expenditures, plus $0.075 million of acquisition-related working-capital payments and $0.081 million of cash interest, reconciles to reported free cash flow of $64.778 million. Conventional operating cash flow less capital expenditures was approximately $64.6 million. The difference is small, but the distinction matters for precise comparisons.

Capital expenditures increased from approximately $9.6 million in Q2 to $39.6 million in Q3. Consequently, approximately $30.0 million of the $42.5 million sequential operating-cash-flow increase was absorbed by additional capital spending. The remaining increase supported higher free cash flow. This is consistent with a company generating cash while entering a more capital-intensive expansion phase.

Working-capital indicators were generally constructive but not sufficient to establish a complete recurring cash-conversion bridge. Accounts receivable declined approximately $3.1 million despite higher revenue, while inventory increased approximately $8.2 million. Deferred revenue increased approximately $12.6 million. The latter can support cash flow but is not equivalent to an independently disclosed order backlog. The release does not establish a precise cash normalization for the tariff refunds or isolate every working-capital timing effect.

The reduction in 2026 Farmers Branch cash capital-expenditure guidance is primarily a timing change. The new range is $100 million to $110 million, compared with $140 million to $170 million previously. The midpoint declines by $50 million, or approximately 32%. Management explicitly stated that project scope, total commitments and ramp velocity were unchanged, with associated cash spending shifting into 2027.

The lower 2026 cash outlay therefore improves near-term free cash flow without proving better lifetime project economics. It would be incorrect to capitalize the change as a permanent reduction in required investment. Management indicated that factory capital investment would remain at similar levels next year but did not provide an unambiguous, fully reconciled 2027 cash budget. The deferred amount should not automatically be added to another assumed 2027 budget without confirming what that budget includes.

The approximately $399 million cash-and-investments figure includes approximately $3.6 million of restricted cash. Unrestricted cash and marketable securities were approximately $395.4 million. Reported debt was approximately $11.4 million, implying approximately $384.1 million of net cash before lease liabilities. Liquidity therefore appears adequate for the planned ramp even before the strategic investment, although project-level returns remain unquantified.

Equity compensation deserves separate consideration. No shares were repurchased during Q3, and the release shows no repurchases during the first 9 months of 2026. Approximately $70.9 million remained under the authorization. Separately, financing cash flows included $35.6 million of year-to-date withholding payments associated with equity awards. Subtracting those payments from company-defined year-to-date free cash flow of $148.1 million leaves approximately $112.4 million before employee share-issuance proceeds and other financing considerations. This is an analytical cash-after-withholding measure, not company-reported free cash flow, and the withholding payments should not also be deducted as an additional current-period compensation expense.

THE LONG-TERM MODEL AND ILLUSTRATIVE 2027 OUTCOMES

The reiterated target model is $1.6 billion of revenue, 55% adjusted gross margin and $5 adjusted EPS. The prior Q2 discussion identified this as the 2030 framework. Relative to the approximately $1.050 billion revenue implied for 2026, reaching $1.6 billion would require approximately 52% cumulative growth, or approximately 11% annually over 4 years. That hurdle is less demanding than current growth, but cannot be evaluated independently of capacity additions and semiconductor cyclicality.

The gross-margin target is now only approximately 200 basis points above management’s underlying baseline. At $1.6 billion of revenue, 200 basis points represent $32 million of annual pretax profit, equivalent to approximately $0.32 per share using a 17% tax rate and 82 million diluted shares. Much of the remaining EPS opportunity therefore depends on revenue expansion and operating leverage, rather than another comparably large step-change in gross margin.

Illustrative 2027 scenarios clarify the sensitivity, but are not company guidance or consensus estimates. A common modeling framework assumes 82 million diluted shares, a 17% effective tax rate and $20 million of annual pretax-equivalent net nonoperating income. The share assumption approximately accommodates the Teradyne issuance, while actual equity-compensation dilution, investment income and acquisition activity could change the outcome. The probabilities are subjective analytical weights, with moderate-to-low confidence because demand commitments and detailed factory economics were not disclosed.

A base case with a 50% probability assumes $1.33 billion of revenue, 53% gross margin and $295 million of adjusted operating expenses, producing approximately $4.35 of adjusted EPS. The revenue framework can be interpreted as the approximately $1.14 billion Q4 midpoint annualized base, plus approximately $150 million of net incremental capacity-related revenue and approximately $40 million of additional growth elsewhere. This assumes meaningful but incomplete conversion of the linear factory opportunity, with transfers and qualification friction preventing full incremental realization.

A bull case with a 25% probability assumes $1.43 billion of revenue, 54.5% gross margin and $300 million of operating expenses, producing approximately $5.05 of adjusted EPS. This requires strong utilization, successful conversion of multiple GPU and ASIC programs, additional photonics growth and better absorption than the current approximately 53% margin framework. It demonstrates that the $5 target could be approached earlier under favorable conditions, but the call does not establish those conditions as the expected outcome.

A bear case with a 25% probability assumes $1.10 billion of revenue, 49% gross margin and $295 million of operating expenses, producing approximately $2.67 of adjusted EPS. This reflects weaker demand or qualification conversion, insufficient utilization and costs that remain relatively inflexible during the ramp. The downside mechanism is not necessarily technological displacement. A delay between installed capacity and revenue realization can produce substantial earnings compression even if long-term demand remains attractive.

The probability-weighted EPS across these scenarios is approximately $4.11. That is not a price target or expected stock return. At the approximately $134.24 strategic transaction price, the illustrative base-case EPS implies approximately 30.8x earnings, while the $5 long-term target implies approximately 26.8x. The transaction price is neither a current market quote nor a valuation floor, and a strategic investor can have economic objectives beyond those of a portfolio investor. Nevertheless, it illustrates why strong operating progress does not automatically establish inexpensive equity valuation.

INVESTMENT IMPLICATIONS, CATALYSTS AND DISCONFIRMING EVIDENCE

The quarter strengthens the case that FormFactor is becoming a more profitable supplier of increasingly complex semiconductor-test interfaces rather than merely participating in a favorable product-mix cycle. Underlying margin improvement during a DDR5-heavy quarter, initial GPU production shipments, broader CPU exposure and rapid photonics commercialization all support that interpretation. The evidence is strongest for the improvement already achieved in manufacturing economics. Confidence is lower regarding the magnitude and timing of prospective share gains.

The near-term catalyst is Q4 execution against guidance, especially normalized profitability after the remaining tariff refunds and the transition of factory costs into cost of revenues. The next major operating catalyst is progressive customer-qualified output from Farmers Branch during the first half of 2027. The larger financial catalyst should occur later in 2027 as the linear ramp produces more meaningful capacity. Successful completion also creates potential 2028 growth through annualization of capacity that was available for only part of 2027.

The most informative indicators are saleable output rather than installed equipment, qualified production designs rather than development engagements, and normalized operating profit rather than gross-margin presentation alone. Additional disclosure on GPU and ASIC production breadth, customer acceptance schedules, factory utilization and the cost burden associated with each released phase would materially improve confidence in the earnings trajectory.

The principal disconfirming evidence would be shipment delays despite strong stated demand, recurring gross margins materially below approximately 53%, production-quality issues, weak utilization after customer qualifications, or a factory ramp that requires materially more spending without corresponding output. A return of substantial DRAM mix sensitivity would also challenge the claim that cost reductions have structurally improved the business. Photonics orders that become concentrated in a narrow deployment cycle would reduce the value of the diversification argument.

Portfolio diversification should not be overstated. Exposure across CPUs, GPUs, custom ASICs, HBM and photonics reduces dependence on individual architectures, but these businesses remain linked to common AI infrastructure budgets, leading-edge foundry capacity and semiconductor investment cycles. A position added alongside substantial AI hardware, memory and test-equipment exposure can increase portfolio correlation despite the diversity of FormFactor’s product categories.

The earnings-based recommendation is to raise the recurring profitability baseline, retain a constructive long bias and avoid increasing exposure solely on the reported margin record. Any new position should be conditional on an acceptable valuation against approximately $0.93 of current normalized quarterly earnings and realistic factory-conversion assumptions. A portfolio-specific position size, absolute entry price and price stop cannot be established from these earnings materials alone. The relevant fundamental exit conditions are failed ramp conversion, sustained underlying margin deterioration, or evidence that anticipated share gains are not translating into commercial revenue.

The decisive distinction is between a stronger business and an automatically attractive stock. Q3 provides substantial evidence for the former. The latter depends on the price paid for factory execution, sustainable profitability and the future revenue contribution of newly qualified programs.

SOURCE BASIS AND INTERPRETIVE LIMITATIONS

The analysis uses the October 28, 2026 earnings-call transcript and supplied Bloomberg notice, FormFactor’s October 28 and July 29 earnings releases, relevant July earnings-call disclosures, the October 12 Teradyne collaboration announcement, the October 13 transaction filing and the October 22 factory-opening announcement. Consensus comparisons use the supplied Bloomberg figures consistently. Normalized earnings, capacity-ramp calculations and 2027 scenarios are analytical estimates, not management guidance. Detailed supplementary PDF tables were not independently readable, so unsupported customer percentages and precise end-market revenue splits have not been reconstructed.

COMPANY EMPLOYEES ON THE CALL

• Mike Slessor, Chief Executive Officer.
• Aric McKinnis, Chief Financial Officer.
• Stan Finkelstein, Vice President of Investor Relations.

RESEARCH ANALYSTS ON THE CALL

• Krish Sankar, identified in the transcript as Sreekrishnan Sankarnarayanan, TD Cowen.
• Craig Ellis, B. Riley Securities.
• George Brown, Deutsche Bank.
• Matthew Prisco, Cantor Fitzgerald.
• Elizabeth Sun, identified in the transcript as Yiling Sun, Citi.
• Charles Shi, identified in the transcript as Yu Shi, Needham.
• Brian Chin, Stifel.